Do saw palmetto extracts block human α1-adrenoceptor subtypes in vivo?

Prostate

Volumn 46, Issue 3, 2001, Pages 226-232

  Goepel, Mark ^a   Dinh, Lin ^a   Mitchell, Anna ^a   Schfers, Rafael F ^a   Rbben, Herbert ^a   Michel, Martin C ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

1 adrenoceptor; Blood pressure; Radioreceptor assay; Saw palmetto

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; FINASTERIDE; STEROID 5ALPHA REDUCTASE;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; HEART RATE; HUMAN; MALE; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RADIORECEPTOR ASSAY; SABAL; SUPINE POSITION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; HUMANS; MALE; NOREPINEPHRINE; PLACEBOS; PLANT EXTRACTS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA-1; SERENOA;

EID: 0035130560     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20010215)46:3<226::AID-PROS1027>3.0.CO;2-R     Document Type: Article

References (23)

1. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States
2. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
3. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia
4. Tamsulosin: Real life clinical experience in 19,365 patients
5. Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review
6. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH
7. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
8. Kombination aus sabal- und urticaextrakt vs. finasterid bei BPH (Stad. I bis II nach Alken). Vergleich der therapeutischen wirksamkeit in einer einjährigen doppelblindstudie
9. Comparison of finasteride (Proscar), a 5α-reductase inhibitor, and various commercial plant extracts in in vitro and in in vivo 5α-reductase inhibition
10. Antiphlogistische wirkung eines mit hyperkritischem kohlendioxid gewonnenen sabalfrucht-extraktes. In-vitro-hemmung des cyclooxygenase- und 5-lipoxygenase-metabolismus
11. 1-adrenoceptors in vitro
12. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics
13. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing
14. 1-Adrenoceptor subtypes differentially couple to growth promotion and inhibition in chinese hamster ovary cells
15. Profund increase in epinephrine concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification
16. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots
17. 2-adrenoceptor-mediated effects in humans
18. 2-cholinoceptor occupancy
19. 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and β-adrenoceptor subtype specific occupancy of celiprolol in healthy man
20. 1-adrenoceptor antagonist: Pharmacodynamic and pharmacokinetic properties
21. Angiotensin II antagonism and plasma radio-receptor-kinetics of candesartan in man
22. Tolerability of α-blockade with doxazosin as a therapeutic option for symptomatic benign prostatic hyperplasia in the elderly patient: A pooled analysis of seven double-blind, placebo-controlled studies
23. 1-adrenoceptor-binding material in rat plasma following a single oral administration of naftopidil